Professor Ramon Shaban, Clinical Chair
Communicable Disease Control and Infection Prevention, Western Sydney Health Precinct
SYDNEY, AUSTRALIA
Bench Side Story continues with a Clinical Chair and Director of Communicable Disease Control and Infection Prevention at Western Sydney Local Health District,
Professor Ramon Z. Shaban, Clinical Chair and Director of Communicable Disease Control and Infection Prevention at the Western Sydney Local Health District, is the lead investigator and project director of the project which has received a 2022 MRFF (Medical Research Future Fund) Clinician Researchers – Nurse, Midwives and Allied Health grant for AUD$1.4 million.
You Might also like
-
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
-
Engineering bacteria to detect colorectal cancer cells
An international team of researchers from Adelaide and the United States has engineered bacteria capable of detecting mutated DNA released from colorectal cancer cells, opening the door to faster disease detection.
-
Biostatistics in Clinical Trials
As a biostatistician working in research and clinical settings, Kate Francis plays a vital role in ensuring all projects adhere to best practice guidelines and are transparently reported. She has served as the lead statistician for the analysis of clinical trials across a broad range of subject areas, including neonatal resuscitation, BCG for allergy and infection, convulsive status epilepticus and her work has been published in the top journals such as The New England Journal of Medicine, JAMA, and The Lancet. Most recently she was awarded the 2025 Excellence in Trial Statistics Award for her work on the PLUSS trial.